Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
8 Results Found
Fact Sheet: The 340B Drug Pricing Program
Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and communities they serve.
Resources to Address 340B Underpayments by Medicare Advantage Organizations
To assist members in their efforts to obtain reimbursement under their contracts with their MAO plans, we have identified and spoken with four outside law firms that have considerable experience with 340B questions and litigating against insurers on issues like these.
Amicus Brief: AHA, Hospital Groups Urge Appeals Courts to Uphold 340B Requirements Re: Novartis-United Therapeutics Corp. v. Johnson
The AHA, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, and Children’s Hospital Association yesterday urged the U.S. Courts of Appeals for the 3rd and District of Columbia Circuits to require drug companies to fulfill their legal obligations to provide 340B discounted drugs to eligible hospitals and health systems, regardless of whether the drugs are dispensed on site or through contract pharmacies.
Judge Orders HHS to Immediately Halt Unlawful Reimbursement Cuts for Remainder of 2022
Judge orders HHS to immediately halt unlawful reimbursement cuts for remainder of 2022 re: 340B.
AHA's Reply in Support of Plaintiffs’ Motion to Vacate the Unlawful Portion of the 2022 OPPS Rule Re: 340B
AHA files reply brief as district court considers 340B payment remedy for the remainder of 2022.
AHA 340B Advocacy Alliance Bulletin: Supreme Court Will Take up AHA’s 340B Challenge
The Supreme Court of the United States today decided to take up AHA’s petition asking to reverse a federal appeals court decision that significantly cuts payments to certain hospitals that participate in the 340B Drug Pricing Program, threatening access to care in communities.
Special Bulletin: Court Rules HHS’s Payment Cut for 340B Hospitals Was Unlawful
A federal judge today ruled in favor of the AHA and hospital plaintiffs saying that the Department of Health and Human Services “adjustment” by nearly 30 percent of 2018 Medicare payment rates for
340B Payment Reductions in the CY2018 Final OPPS Rule
AHA, Associations, Hospitals Remedies Brief (January 31, 2019)